Status: Recruiting
A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants
The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.
Participants needed: 80
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: AbbVieUpdated: Aug 21, 2026Locations: 5
Eligibility criteria
Participant must have moderate (Grade 2) or severe (Grade 3) forehead lines (FHL... [+2]
Clinically relevant or significant ECG abnormalities. [+1]